Literature DB >> 22670674

MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts.

Kyu-Yeon Han1, Daoud C Fahd, Makambo Tshionyi, Norma Allemann, Sandeep Jain, Jin-Hong Chang, Dimitri T Azar.   

Abstract

The cornea is physiologically avascular. Following a corneal injury, wound healing often proceeds without neovascularization (NV); however, corneal NV may be induced during wound healing in certain inflammatory, infectious, degenerative, and traumatic states. Such states disrupt the physiologic balance between pro-angiogenic and antiangiogenic mediators, favoring angiogenesis. Contributors to such states are matrix metalloproteinases (MMPs), which are key factors in both extracellular matrix remodeling and angiogenesis. Similarly, vascular endothelial growth factor A (VEGF-A) and basic fibroblast growth factor (bFGF) exert pro-angiogenic effects. Here, we elaborate on the facilitative role of MMPs-specifically Membrane Type 1 MMP (MT1-MMP, MMP14)-in corneal NV. Additionally, we provide new insight into the signaling relating to MT1-MMP, Ras, and ERK in the bFGF-induced VEGF-A expression pathways within the corneal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670674      PMCID: PMC3653774          DOI: 10.2174/092986612803521639

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  41 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  Corneal neovascularization.

Authors:  J H Chang; E E Gabison; T Kato; D T Azar
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

Review 3.  The cell surface: the stage for matrix metalloproteinase regulation of migration.

Authors:  Motoharu Seiki
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

4.  MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.

Authors:  N E Sounni; L Devy; A Hajitou; F Frankenne; C Munaut; C Gilles; C Deroanne; E W Thompson; J M Foidart; A Noel
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

5.  Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP).

Authors:  D Gingras; N Bousquet-Gagnon; S Langlois; M P Lachambre; B Annabi; R Béliveau
Journal:  FEBS Lett       Date:  2001-10-26       Impact factor: 4.124

6.  Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma.

Authors:  Przemyslaw Przewratil; Anna Sitkiewicz; Ewa Andrzejewska
Journal:  Growth Factors       Date:  2010-09-21       Impact factor: 2.511

7.  Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.

Authors:  H Q Ye; M Maeda; F S Yu; D T Azar
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

8.  Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis.

Authors:  Y S Kanwar; K Ota; Q Yang; J Wada; N Kashihara; Y Tian; E I Wallner
Journal:  Am J Physiol       Date:  1999-12

Review 9.  Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis.

Authors:  N E Sounni; M Janssen; J M Foidart; A Noel
Journal:  Matrix Biol       Date:  2003-03       Impact factor: 11.583

10.  Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.

Authors:  Borhane Annabi; Ying-Ta Lee; Sandra Turcotte; Emmanuelle Naud; Richard R Desrosiers; Martin Champagne; Nicoletta Eliopoulos; Jacques Galipeau; Richard Béliveau
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

View more
  11 in total

Review 1.  Nanotechnology in corneal neovascularization therapy--a review.

Authors:  Lilian Gonzalez; Raymond J Loza; Kyu-Yeon Han; Suhair Sunoqrot; Christy Cunningham; Patryk Purta; James Drake; Sandeep Jain; Seungpyo Hong; Jin-Hong Chang
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-20       Impact factor: 2.671

Review 2.  Molecular underpinnings of corneal angiogenesis: advances over the past decade.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

3.  Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice.

Authors:  Jimmy Zhu; Jennifer Dugas-Ford; Michael Chang; Patryk Purta; Kyu-Yeon Han; Young-Kwon Hong; Mary E Dickinson; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  FEBS J       Date:  2015-03-06       Impact factor: 5.542

4.  Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.

Authors:  Pinjing Hui; Xu Xu; Lan Xu; Guozhen Hui; Shiliang Wu; Qing Lan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  MMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic Effect.

Authors:  Kyu-Yeon Han; Jennifer Dugas-Ford; Hyun Lee; Jin-Hong Chang; Dimitri T Azar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

6.  Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts.

Authors:  Kyu-Yeon Han; Jennifer Dugas-Ford; Motoharu Seiki; Jin-Hong Chang; Dimitri T Azar
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-11       Impact factor: 4.799

Review 7.  Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Authors:  Jin-Hong Chang; Yu-Hui Huang; Christy M Cunningham; Kyu-Yeon Han; Michael Chang; Motoharu Seiki; Zhongjun Zhou; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2015-12-02       Impact factor: 6.048

8.  Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.

Authors:  Kyu-Yeon Han; Jin-Hong Chang; Jennifer Dugas-Ford; Jonathan S Alexander; Dimitri T Azar
Journal:  FEBS Lett       Date:  2014-10-02       Impact factor: 4.124

9.  MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.

Authors:  Nikita G Alexiades; Brenda Auffinger; Chung Kwon Kim; Tanwir Hasan; Gina Lee; Marc Deheeger; Alex L Tobias; Janice Kim; Irina Balyasnikova; Maciej S Lesniak; Karen Aboody; Atique U Ahmed
Journal:  Stem Cell Res       Date:  2015-10-22       Impact factor: 2.020

10.  Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.

Authors:  Tong Lin; Lan Gong
Journal:  Drug Des Devel Ther       Date:  2017-04-05       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.